Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M C Le Deley

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
ESMO Open|September 18, 2022
Association between recent pregnancy or hormonal contraceptive exposure and outcome of desmoid-type fibromatosisM Debaudringhien, J-Y Blay, A-M Bimbai, et al.
Pediatric Blood & Cancer|January 24, 2017
Investigating the heterogeneity of alkylating agents' efficacy and toxicity between sexes: A systematic review and meta-analysis of randomized trials comparing cyclophosphamide and ifosfamide (MAIAGE study)Brice Fresneau, A Hackshaw, D S Hawkins, et al.
European Journal of Cancer (Oxford, England : 1990)|February 25, 2019
Continuation versus discontinuation of first-line chemotherapy in patients with metastatic squamous cell oesophageal cancer: A randomised phase II trial (E-DIS)A Adenis, J Bennouna, P L Etienne, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 24, 2023
ctDNA quantification improves estimation of outcomes in patients with high-grade osteosarcoma: a translational study from the OS2006 trialB Audinot, D Drubay, N Gaspar, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
ESMO Open|September 18, 2022
Association between recent pregnancy or hormonal contraceptive exposure and outcome of desmoid-type fibromatosisM Debaudringhien, J-Y Blay, A-M Bimbai, et al.
Pediatric Blood & Cancer|January 24, 2017
Investigating the heterogeneity of alkylating agents' efficacy and toxicity between sexes: A systematic review and meta-analysis of randomized trials comparing cyclophosphamide and ifosfamide (MAIAGE study)Brice Fresneau, A Hackshaw, D S Hawkins, et al.
European Journal of Cancer (Oxford, England : 1990)|February 25, 2019
Continuation versus discontinuation of first-line chemotherapy in patients with metastatic squamous cell oesophageal cancer: A randomised phase II trial (E-DIS)A Adenis, J Bennouna, P L Etienne, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 24, 2023
ctDNA quantification improves estimation of outcomes in patients with high-grade osteosarcoma: a translational study from the OS2006 trialB Audinot, D Drubay, N Gaspar, et al.
Pageof 3